AIM at Melanoma - Reshaping the Future Together

Living With Melanoma Symposiums

Bringing together leading medical and wellness professionals with people affected by melanoma to learn, connect, and share.

Fall Schedule

The Stages of Melanoma

Comprehensive physician-reviewed information about melanoma, including stages of melanoma, warning sign photos, and risk factors.

Stages of Melanoma

Life With Melanoma

Resources to help better understand melanoma and manage your life through treatment and recovery.

The Melanoma Learning Center

One Goal: Discover the Cure

Our global initiatives are fundamentally changing the face and future of melanoma research.

Our Research Initiatives

Walks & Fun Runs

Help us increase melanoma awareness and raise money to support research.

Join Our Cause

Groundbreaking

Research

Working Group

Tissue Bank

Education & Support

Stages of Melanoma

Reshaping the Future Together

Fundraising

AIM Walks & Fun Runs

Donate

AIM Fundraisers & Partner Programs

Sponsor Events

Speak with our Oncology Nurse

Here for you. When you need answers. Free of Charge. 100% confidential.

I Have a Question

or call 1-877-246-2635

Search for a Melanoma Specialist

Clinical Trials Matching Service

See Details

Melanoma Education

From risk factors, to melanoma stages, to treatment, and beyond

Learn More »

Innovative Research

Changing the face and future of melanoma research to discover the CURE

Learn More »

Global Engagement & Advocacy

Most influential voice in melanoma, locally and globally

Learn More »

Leading the Way in Legislation

Leading and winning legislative and regulatory change across the country

Learn More »

Melanoma News & Events

News 10/22/2018

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma

News 10/21/2018

Dynavax's SD-101 in Combination with KEYTRUDA(R) (pembrolizumab) Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients

News 10/19/2018

Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma

News 10/19/2018

Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma

Event 10/13/2018

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - SALT LAKE CITY, UT

Event 09/29/2018

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - HOUSTON, TX

Event 09/17/2018

Melanoma, Vitiligo and XP Patient Symposium

Event 09/16/2018

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - WATERTOWN, NY

News 09/10/2018

NICE Turns Down Opdivo for Adjuvant Melanoma Therapy

News 09/06/2018

Melanoma By The State: Vermont

News 09/06/2018

Survivor Spotlight: Amy Flavin, Stage IIA

News 09/06/2018

Living With Melanoma Symposiums

The Stages of Melanoma

Life With Melanoma

One Goal: Discover the Cure

Walks & Fun Runs

Research

Stages of Melanoma

Fundraising

Speak with our Oncology Nurse

Search for a Melanoma Specialist

Clinical Trials Matching Service

Melanoma Education

Innovative Research

Global Engagement & Advocacy

Leading the Way in Legislation

Melanoma News & Events

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma

Dynavax's SD-101 in Combination with KEYTRUDA(R) (pembrolizumab) Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients

Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma

Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - SALT LAKE CITY, UT

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - HOUSTON, TX

Melanoma, Vitiligo and XP Patient Symposium

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - WATERTOWN, NY

NICE Turns Down Opdivo for Adjuvant Melanoma Therapy

Melanoma By The State: Vermont

Survivor Spotlight: Amy Flavin, Stage IIA

Women In Melanoma: AIM’s Latest Success Story

Please keep me informed.